Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Curalogic picks SAFC for biotech separation services

Swiss chemical maker will work with Germany's Max Planck Institute

by Alexander H. Tullo
October 30, 2006 | A version of this story appeared in Volume 84, Issue 44

SAFC, the fine chemicals arm of Sigma-Aldrich, has been chosen to provide chemical development services for Danish biopharmaceutical firm Curalogic. SAFC will provide protein isolation, extraction, and purification services for Curalogic's immunotherapies for allergy sufferers. SAFC chemists will initially develop a pharmaceutical-grade process for extracting compounds that treat allergies due to grass and dust mites. The first phases of the project will be done at SAFC's existing protein purification and extraction facility in St. Louis. Eventually, the project will be transferred to a facility now under construction at the site.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.